Cambium Networks (NASDAQ: CMBM) shares shift from Nasdaq to OTC markets
Rhea-AI Filing Summary
Cambium Networks Corporation filed an amended report to correct how it described future trading of its ordinary shares following a Nasdaq delisting decision. The company now states that trading is expected to move first to the OTC Pink Limited tier and then to the Expert Market under the symbol CMBM.
Nasdaq’s Hearings Panel decided on March 25, 2026 to delist Cambium’s ordinary shares for failure to comply with milestones in a prior decision, and trading on Nasdaq will be suspended at the open on March 27, 2026. Cambium is considering whether to appeal to the Nasdaq Listing and Hearing Review Council, but any appeal would not prevent the suspension. The company warns that trading on OTC Pink and the Expert Market may materially reduce share price and volume and make it harder for shareholders to buy or sell shares.
Positive
- None.
Negative
- Nasdaq delisting and trading suspension: The Nasdaq Hearings Panel decided on March 25, 2026 to delist Cambium Networks’ ordinary shares, with Nasdaq trading suspended at the open on March 27, 2026 after failure to meet required milestones.
- Migration to OTC Pink and Expert Market: The company expects its shares to move to the OTC Pink Limited tier and then to the Expert Market, which it warns may materially reduce trading price and volume and make buying or selling shares more difficult.
- Heightened liquidity and volatility risks: Cambium states that investors may experience reduced liquidity, less transparency, and greater price volatility once trading shifts to OTC Pink and the Expert Market.
Insights
Nasdaq delisting and shift to OTC markets create a clearly negative trading event for Cambium Networks shareholders.
Cambium Networks has received a Nasdaq Hearings Panel decision to delist its ordinary shares after it failed to meet periodic filing milestones set in a prior decision. Trading on Nasdaq will be suspended at the open on March 27, 2026, removing the stock from a major national exchange.
The company expects its shares to move to the OTC Pink Limited tier and then to the Expert Market. It explicitly notes this may have a material adverse effect on trading price and volume, with investors facing reduced liquidity, less transparency, and greater price volatility. These characteristics are typical of thinly traded OTC and Expert Market securities.
Cambium is considering an appeal to the Nasdaq Listing and Hearing Review Council, but the filing states that such a request would not stay the suspension of trading on Nasdaq. Subsequent company communications and filings will clarify whether an appeal is pursued and whether any path back to an exchange listing is established.
8-K Event Classification
FAQ
What did Cambium Networks (CMBM) announce about its Nasdaq listing?
Is Cambium Networks appealing the Nasdaq delisting decision?
Why was Cambium Networks found non-compliant with Nasdaq requirements?
What was corrected by Cambium Networks’ amended 8-K/A filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Explanatory Note
This Amendment No. 1 on Form 8-K/A is being filed solely for the purpose to correct this to state the trading of the Company's Ordinary Shares is expected to initially move to the OTC Pink Limited tier and then go into the Expert Market as disclosed in the Press Release attached as Exhibit 99.1 in the Original Form 8-K.
This Amendment does not otherwise change or affect any previously reported information contained in the Original Form 8-K.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On March 25, 2026, Cambium Networks Corporation (“Cambium” or the “Company”) received a written notice (the “Delist Determination”) that the Nasdaq Hearings Panel (the “Hearings Panel”) has determined to delist the Ordinary Shares of the Company from The Nasdaq Stock Market (“Nasdaq”) due to the Company's failure to comply with the terms of the Hearings Panel's Decision.
Trading in the Company's Ordinary Shares will be suspended at the open of trading on March 27, 2026.
The Company is considering whether to request an appeal of the Delist Determination to the Nasdaq Listing and Hearing Review Council (the “Council”) in accordance with Nasdaq Listing Rule 5820(a). Such request would not stay the suspension of trading the Ordinary Shares on Nasdaq. The Company expects the Ordinary Shares will initially move to the OTC Pink Limited tier and then go into the Expert Market under its trading symbol “CMBM”, which may have a material adverse effect on the trading price and volume for the Ordinary Shares. There can be no assurance that a market for the Ordinary Shares will develop or be maintained on the Expert Market, and the Company's shareholders may find it more difficult to buy or sell their shares.
On March 26, 2026, the Company issued a press release announcing its receipt of the Delist Determination. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.
Forward-Looking Statements
This Current Report on Form 8-K contains forward-looking statements, including, but not limited to statements relating to the Company's plan to appeal the Delist determination and the Company's eligibility to trade on the OTC Markets system, as well as words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “seeks,” “assumes,” “may,” “should,” “could,” “would,” and variations of such words and similar expressions are intended to identify such forward-looking statements. These forward-looking statements are based upon the Company’s current assumptions, beliefs, and expectations. Forward-looking statements are subject to the occurrence of many events outside of the Company’s control. Actual results and the timing of events may differ materially from those contemplated by such forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things, the Company’s ability to successfully appeal the Delist determination. Forward-looking statements should be considered in light of these risks and uncertainties. Investors and others are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained herein speak only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law.
Item 9.01 Financial Statements and Exhibits.
99.1 |
Press release dated March 26, 2026 |
104 |
Cover Page Interactive Data File (formatting in Inline XBRL and contained in Exhibit 101) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
CAMBIUM NETWORKS CORPORATION |
|
|
|
|
Date: |
March 26, 2026 |
By: |
/S/ Sally Rau |
|
|
Name: Title: |
Sally Rau |
